Results 141 to 150 of about 2,667 (188)

Paroxysmal Nocturnal Hemoglobinuria: Unraveling Its Molecular Pathogenesis and Advancing Targeted Therapeutic Strategies. [PDF]

Diseases
Apostolidou E, Georgoulis V, Leonardos D, Kapsali E, Hatzimichael E.   +4 more
europepmc   +1 more source

Managing transient immune complex reactions in patients with paroxysmal nocturnal hemoglobinuria: clinical observations from the COMMODORE 1 and 2 studies. [PDF]

Ther Adv Hematol
Kulasekararaj AG, Nishimura JI, Röth A, Beveridge L, Buatois S, Buri M, Compagno N, Luder Y, Sreckovic S, Scheinberg P.   +9 more
europepmc   +1 more source

Ravulizumab for paroxysmal nocturnal haemoglobinuria

, 2022
openaire   +1 more source

Pharmacological Therapies in Paroxysmal Nocturnal Haemoglobinuria: Focus on Complement Inhibition. [PDF]

Drugs
Kelly RJ, Holt M, Szer J.
europepmc   +1 more source

Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis. [PDF]

J Neurol
John N, Lim A, Sunthar SR, Zhang L, Cheng J, Boktor J, Chong V, Ma H, Phan TG.   +8 more
europepmc   +1 more source

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma. [PDF]

Cureus
Takahata A, Tanaka K, Toyota S.
europepmc   +1 more source

Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome. [PDF]

Hematology Am Soc Hematol Educ Program
Cole MA.
europepmc   +1 more source

The varieties of therapeutic experience: navigating treatment options for patients with PNH. [PDF]

Hematology Am Soc Hematol Educ Program
Bienz M, Patriquin CJ.
europepmc   +1 more source

Effectiveness and safety of ravulizumab for Japanese patients with atypical hemolytic uremic syndrome switched from eculizumab: an analysis of a post-marketing surveillance. [PDF]

Clin Exp Nephrol
Ito S, Hataya H, Matsumoto M, Shimono A, Teranishi H, Okuda M, Miyakawa Y, Maruyama S.   +7 more
europepmc   +1 more source

First report of perioperative iptacopan interruption in paroxysmal nocturnal hemoglobinuria without breakthrough hemolysis. [PDF]

Hematol Transfus Cell Ther
Tokuda K, Morioka T, Arai S, Matsuo T, Matsumoto K, Shirasaki R, Ooi J, Tashiro H.   +7 more
europepmc   +1 more source